The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill Patients

Clinics in Chest Medicine

Volumn 29, Issue 4, 2008, Pages 617-625

  Ward, Nicholas S ^a   Casserly, Brian ^a   Ayala, Alfred ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Anergy; Anti inflammatory; Compensatory anti inflammatory response syndrome; Human leukocyte antigen; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

COMPENSATORY ANTIINFLAMMATORY RESPONSE SYNDROME; CRITICALLY ILL PATIENT; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; CLONAL ANERGY; CRITICAL ILLNESS; DOWN-REGULATION; HLA-DR ANTIGENS; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; LYMPHOCYTES; MONOCYTES; SEPSIS; SUPPRESSOR FACTORS, IMMUNOLOGIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 54049130105     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.06.010     Document Type: Review

References (77)

1. Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24 7 (1996) 1125-1128
2. Freeman B.D., and Natanson C. Anti-inflammatory therapies in sepsis and septic shock. Expert Opin Investig Drugs 9 7 (2000) 1651-1663
3. MacLean L.D., Meakins J.L., Taguchi K., et al. Host resistance in sepsis and trauma. Ann Surg 182 3 (1975) 207-217
4. Munster A.M. Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet 1 7973 (1976) 1329-1330
5. Meakins J.L., Pietsch J.B., Bubenick O., et al. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg 186 3 (1977) 241-250
6. Miller C.L., and Baker C.C. Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest 63 2 (1979) 202-210
7. Wolfe J.H., Wu A.V., O'Connor N.E., et al. Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch Surg 117 10 (1982) 1266-1271
8. Oberholzer A., Oberholzer C., and Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16 2 (2001) 83-96
9. Shelley O., Murphy T., Paterson H., et al. Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 20 2 (2003) 123-129
10. Daniels J.C., Sakai H., Cobb E.K., et al. Evaluation of lymphocyte reactivity studies in patients with thermal burns. J Trauma 11 7 (1971) 595-601
11. Hensler T., Hecker H., Heeg K., et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 65 6 (1997) 2283-2291
12. O'Mahony J.B., Wood J.J., Rodrick M.L., et al. Changes in T lymphocyte subsets following injury. Assessment by flow cytometry and relationship to sepsis. Ann Surg 202 5 (1985) 580-586
13. Abraham E., and Chang Y.H. The effects of hemorrhage on mitogen-induced lymphocyte proliferation. Circ Shock 15 2 (1985) 141-149
14. Bandyopadhyay G., De A., Laudanski K., et al. Negative signaling contributes to T-cell anergy in trauma patients. Crit Care Med 35 3 (2007) 794-801
15. Stephan R.N., Kupper T.S., Geha A.S., et al. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 122 1 (1987) 62-68
16. Heidecke C.D., Hensler T., Weighardt H., et al. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg 178 4 (1999) 288-292
17. O'Sullivan S.T., Lederer J.A., Horgan A.F., et al. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222 4 (1995) 482-490 discussion 490-482
18. Rodrick M.L., Wood J.J., Grbic J.T., et al. Defective IL-2 production in patients with severe burns and sepsis. Lymphokine Res 5 Suppl 1 (1986) S75-S80
19. Puyana J.C., Pellegrini J.D., De A.K., et al. Both T-helper-1- and T-helper-2-type lymphokines are depressed in posttrauma anergy. J Trauma 44 6 (1998) 1037-1045 discussion 1045-1036
20. Wick M., Kollig E., Muhr G., et al. The potential pattern of circulating lymphocytes TH1/TH2 is not altered after multiple injuries. Arch Surg 135 11 (2000) 1309-1314
21. Palmer J.L., Tulley J.M., Kovacs E.J., et al. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells. J Immunol 177 1 (2006) 92-99
22. Schwacha M.G., Ayala A., and Chaudry I.H. Insights into the role of gammadelta T lymphocytes in the immunopathogenic response to thermal injury. J Leukoc Biol 67 5 (2000) 644-650
23. Krakauer T., and Oppenheim J.J. IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J Immunol 150 4 (1993) 1205-1211
24. Fumeaux T., and Pugin J. Is the measurement of monocytes HLA-DR expression useful in patients with sepsis?. Intensive Care Med 32 8 (2006) 1106-1108
25. Volk H.D., Reinke P., and Docke W.D. Immunological monitoring of the inflammatory process: Which variables? When to assess?. Eur J Surg Suppl 584 (1999) 70-72
26. Volk H.D., Reinke P., Krausch D., et al. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22 Suppl 4 (1996) S474-S481
27. Asadullah K., Woiciechowsky C., Docke W.D., et al. Very low monocytic HLA-DR expression indicates high risk of infection-immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. Eur J Emerg Med 2 4 (1995) 184-190
28. van den Berk J.M., Oldenburger R.H., van den Berg A.P., et al. Low HLA-DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. Transplantation 63 12 (1997) 1846-1848
29. Denzel C., Riese J., Hohenberger W., et al. Monitoring of immunotherapy by measuring monocyte HLA-DR expression and stimulated TNFalpha production during sepsis after liver transplantation. Intensive Care Med 24 12 (1998) 1343-1344
30. Haveman J.W., van den Berg A.P., van den Berk J.M., et al. Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake. Transpl Infect Dis 1 3 (1999) 146-152
31. Astiz M., Saha D., Lustbader D., et al. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 128 6 (1996) 594-600
32. Ding Y., Chung C.S., Newton S., et al. Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock 22 2 (2004) 137-144
33. Flohe S.B., Agrawal H., Schmitz D., et al. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response. J Leukoc Biol 79 3 (2006) 473-481
34. Guisset O., Dilhuydy M.S., Thiebaut R., et al. Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med 33 1 (2007) 148-152
35. Hotchkiss R.S., Tinsley K.W., Swanson P.E., et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 168 5 (2002) 2493-2500
36. Toliver-Kinsky T.E., Cui W., Murphey E.D., et al. Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection. J Immunol 174 1 (2005) 404-410
37. Fujita S., Seino K., Sato K., et al. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 107 9 (2006) 3656-3664
38. MacNeil I.A., Suda T., Moore K.W., et al. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145 12 (1990) 4167-4173
39. O'Garra A., Stapleton G., Dhar V., et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 2 9 (1990) 821-832
40. Oberholzer A., Oberholzer C., and Moldawer L.L. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30 1 Supp (2002) S58-S63
41. Berg D.J., Kuhn R., Rajewsky K., et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96 5 (1995) 2339-2347
42. Howard M., Muchamuel T., Andrade S., et al. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177 4 (1993) 1205-1208
43. van der Poll T., Jansen P.M., Montegut W.J., et al. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 158 4 (1997) 1971-1975
44. Remick D.G., Garg S.J., Newcomb D.E., et al. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. Crit Care Med 26 5 (1998) 895-904
45. Steinhauser M.L., Hogaboam C.M., Kunkel S.L., et al. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 162 1 (1999) 392-399
46. Ashare A., Powers L.S., Butler N.S., et al. Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol 288 4 (2005) L633-L640
47. Song G.Y., Chung C.S., Chaudry I.H., et al. What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant?. Surgery 126 2 (1999) 378-383
48. Ayala A., Xin Xu Y., Ayala C.A., et al. Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 91 4 (1998) 1362-1372
49. Hotchkiss R.S., Swanson P.E., Freeman B.D., et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27 7 (1999) 1230-1251
50. Fadok V.A., Bratton D.L., Konowal A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101 4 (1998) 890-898
51. Voll R.E., Herrmann M., Roth E.A., et al. Immunosuppressive effects of apoptotic cells. Nature 390 6658 (1997) 350-351
52. Hotchkiss R.S., Tinsley K.W., Swanson P.E., et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166 11 (2001) 6952-6963
53. Hiramatsu M., Hotchkiss R.S., Karl I.E., and Buchman T.G. Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 7 4 (1997) 247-253
54. Hotchkiss R.S., Swanson P.E., Cobb J.P., et al. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med 25 8 (1997) 1298-1307
55. Le Tulzo Y., Pangault C., Gacouin A., et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 18 6 (2002) 487-494
56. Hotchkiss R.S., Swanson P.E., Knudson C.M., et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 162 7 (1999) 4148-4156
57. Hotchkiss R.S., Tinsley K.W., Swanson P.E., et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 96 25 (1999) 14541-14546
58. Gogos C.A., Drosou E., Bassaris H.P., and Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181 1 (2000) 176-180
59. Keane R.M., Birmingham W., Shatney C.M., et al. Prediction of sepsis in the multitraumatic patient by assays of lymphocyte responsiveness. Surg Gynecol Obstet 156 2 (1983) 163-167
60. Hynninen M., Pettila V., Takkunen O., et al. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock 20 1 (2003) 1-4
61. Oczenski W., Krenn H., Jilch R., et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 29 8 (2003) 1253-1257
62. Perry S.E., Mostafa S.M., Wenstone R., et al. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?. Intensive Care Med 29 8 (2003) 1245-1252
63. Ahlstrom A., Hynninen M., Tallgren M., et al. Predictive value of interleukins 6, 8 and 10, and low HLA-DR expression in acute renal failure. Clin Nephrol 61 2 (2004) 103-110
64. Su L., Zhou D.Y., Tang Y.Q., et al. [Clinical value of monitoring CD14+ monocyte human leukocyte antigen (locus) DR levels in the early stage of sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18 11 (2006) 677-679
65. Zhang Y.T., and Fang Q. [Study on monocyte HLA-DR expression in critically ill patients after surgery]. Zhonghua Wai Ke Za Zhi 44 21 (2006) 1480-1482
66. Allen M.L., Peters M.J., Goldman A., et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 30 5 (2002) 1140-1145
67. Doughty L., Carcillo J.A., Kaplan S., et al. The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 113 6 (1998) 1625-1631
68. Simmons E.M., Himmelfarb J., Sezer M.T., et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65 4 (2004) 1357-1365
69. van Dissel J.T., van Langevelde P., Westendorp R.G., et al. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351 9107 (1998) 950-953
70. Angele M.K., Wichmann M.W., Ayala A., et al. Testosterone receptor blockade after hemorrhage in males. Restoration of the depressed immune functions and improved survival following subsequent sepsis. Arch Surg 132 11 (1997) 1207-1214
71. Angele M.K., Catania R.A., Ayala A., et al. Dehydroepiandrosterone: an inexpensive steroid hormone that decreases the mortality due to sepsis following trauma-induced hemorrhage. Arch Surg 133 12 (1998) 1281-1288
72. Catania R.A., Angele M.K., Ayala A., et al. Dehydroepiandrosterone restores immune function following trauma-haemorrhage by a direct effect on T lymphocytes. Cytokine 11 6 (1999) 443-450
73. Hershman M.J., Appel S.H., and Wellhausen S.R. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clin Exp Immunol 77 1 (1989) 67-70
74. Bundschuh D.S., Barsig J., Hartung T., et al. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol 158 6 (1997) 2862-2871
75. Docke W.D., Randow F., Syrbe U., et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3 6 (1997) 678-681
76. Kox W.J., Bone R.C., Krausch D., et al. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch Intern Med 157 4 (1997) 389-393
77. Nakos G., Malamou-Mitsi V.D., Lachana A., et al. Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 30 7 (2002) 1488-1494